Dual pathway antithrombotic treatment and risk reduction in patients with atherosclerotic cardiovascular disease: A real-world perspective.

Auer, Johann; Auer, Lisa

Dual pathway antithrombotic treatment and risk reduction in patients with atherosclerotic cardiovascular disease: A real-world perspective.

Auer, Johann; Auer, Lisa.

Afiliación

Auer J; Department of Cardiology and Intensive Care, St Josef Hospital, Braunau, Austria; Department of Cardiology and Intensive Care, Kepler University Hospital Linz, Austria; Paracelsus Medical University Salzburg, Austria. Electronic address: johann.auer@khbr.at.
Auer L; Department of Biochemistry and Molecular Biomedicine, Graz, Technical University Graz, Austria.

Atherosclerosis ; 393: 117543, 2024 06.

Article en En | MEDLINE | ID: mdl-38653706

Asunto(s)

Aterosclerosis; Fibrinolíticos; Humanos; Aterosclerosis/tratamiento farmacológico; Aterosclerosis/prevención & control; Fibrinolíticos/uso terapéutico; Fibrinolíticos/efectos adversos; Resultado del Tratamiento; Medición de Riesgo; Femenino; Inhibidores de Agregación Plaquetaria/uso terapéutico; Masculino; Hemorragia/inducido químicamente; Factores de Riesgo; Anciano; Persona de Mediana Edad

Palabras clave

Cardiovascular disease; Dual pathway inhibition; Inflammation; Residual risk; Residual thrombotic risk; Theoretical risks and benefits

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Aterosclerosis / Fibrinolíticos Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Atherosclerosis Año: 2024 Tipo del documento: Article Pais de publicación: Irlanda

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google